David A Owen
Overview
Explore the profile of David A Owen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
540
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Geramizadeh B, Marzban M, Owen D
Iran J Pathol
. 2018 May;
12(1):1-8.
PMID: 29760747
Background: Routine screening colonoscopy is on the rise and pathologists have to deal with the ever larger numbers of excised colonic polyps. It is very important to optimize the patients'...
2.
Owen D, Owen D
Arch Pathol Lab Med
. 2017 Aug;
142(1):35-43.
PMID: 28758791
Context: - Patients who receive an upper gastrointestinal endoscopic examination frequently have biopsies taken from the duodenum. Accurate interpretation of duodenal biopsies is essential for patient care. Celiac disease is...
3.
Geramizadeh B, Owen D
Middle East J Dig Dis
. 2017 Mar;
9(1):5-11.
PMID: 28316760
Endoscopic mucosal resection (EMR) is a non-invasive alternative to surgery that is now frequently used for resection of early lesions in both upper and lower parts of the gastrointestinal (GI)...
4.
Nyborg A, Ward C, Zacco A, Chacko B, Grinberg L, Geoghegan J, et al.
PLoS One
. 2016 Dec;
11(12):e0167935.
PMID: 28002433
Humans and higher primates are unique in that they lack uricase, the enzyme capable of oxidizing uric acid. As a consequence of this enzyme deficiency, humans have high serum uric...
5.
Yapp D, Wong M, Kyle A, Valdez S, Tso J, Yung A, et al.
Angiogenesis
. 2016 Mar;
19(2):229-44.
PMID: 26961182
Background: Metronomic chemotherapy has shown promising activity against solid tumors and is believed to act in an antiangiogenic manner. The current study describes and quantifies the therapeutic efficacy, and mode...
6.
Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups
Leo J, Kalloger S, Peixoto R, Gale N, Webber D, Owen D, et al.
J Clin Pathol
. 2015 Oct;
69(5):431-9.
PMID: 26500334
Background: Ampullary carcinomata (AC) can be separated into intestinal (IT) or pancreatobiliary (PB) subtypes. Although morphological, immunohistochemical and molecular differentiation of IT and PB have been well documented; the prognostic...
7.
OConnor K, Li-Chang H, Kalloger S, Peixoto R, Webber D, Owen D, et al.
Am J Surg Pathol
. 2015 Jan;
39(4):472-8.
PMID: 25634751
Tumor budding is a well-established adverse prognostic factor in colorectal cancer. However, the significance and diagnostic reproducibility of budding in pancreatic carcinoma requires further study. We aimed to assess the...
8.
Verdun T, Owen D
Pathol Res Pract
. 2014 Dec;
211(3):268-70.
PMID: 25468812
Extra-axial ependymomas are exceedingly rare neuroectodermal tumors that arise outside the central nervous system. The majority behave in a benign clinical fashion. In this case, an elderly woman developed an...
9.
Degroote A, Knippenberg L, Vander Borght S, Spaepen M, Matthijs G, Schaeffer D, et al.
Leuk Lymphoma
. 2012 Aug;
54(4):812-8.
PMID: 22916837
In Helicobacter pylori gastritis, constant antigenic stimulation triggers a sustained B-cell proliferation. Errors made during this continuous DNA replication are supposed to be corrected by the DNA mismatch repair mechanism....
10.
Ondrejka S, Schaeffer D, Jakubowski M, Owen D, Bronner M
Am J Surg Pathol
. 2011 Aug;
35(9):1327-30.
PMID: 21836482
To our knowledge, the genotoxic effects of neoadjuvant chemoradiation therapy on molecular diagnostic testing results are unknown. However, if neoadjuvant treatments were to alter molecular test results, clinical decision-making could...